A Pediatric Bench Model of Continuous Albuterol Delivery Using Heliox

Area of Science:

• Pediatric respiratory care
• Pharmacokinetics and drug delivery
• Helium-oxygen (heliox) therapy

Background:

• Optimal continuous albuterol delivery with heliox in pediatrics is not well-established.
• Understanding efficient nebulizer setups is crucial for effective albuterol administration.

Purpose of the Study:

• To compare the efficiency of continuous albuterol delivery with heliox using different nebulizer setups.
• To evaluate albuterol aerosol deposition in a pediatric model under various heliox administration configurations.

Main Methods:

• A pediatric manikin with simulated breathing received continuous albuterol (20 mg/h) with heliox (80/20) via three setups: MiniHEART nebulizer, vibrating mesh nebulizer (VMN) with high-flow nasal cannula (HFNC), and VMN with a non-rebreather mask.
• Both tight-fitting and loose-fitting masks were tested, along with different heliox ratios (70/30 vs. 80/20).
• Drug delivery was quantified using ultraviolet spectrophotometry after collecting aerosol deposition.

Main Results:

• VMN with HFNC and VMN with a tight-fitting mask achieved the highest inhaled albuterol doses (approximately 8.5-8.8%).
• The MiniHEART nebulizer resulted in significantly lower aerosol deposition (1.5%).
• Tight-fitting masks and 80/20 heliox mixtures delivered higher inhaled doses compared to loose-fitting masks and 70/30 heliox, respectively.

Conclusions:

• VMN with HFNC during closed-mouth breathing is the most effective setup for continuous albuterol delivery with heliox in pediatric models.
• This method surpasses the MiniHEART nebulizer and VMN with a loose-fitting mask in terms of inhaled drug dose.
• Findings provide guidance for optimizing heliox-albuterol therapy in pediatric patients.